Dabigatran (Pradaxa, Pradax) for the prevention of VTE. Mechanism of action, indications, contraindications, pharmacodynamics and pharmacokinetics.

Information about dabigatran (Pradaxa in Europe, Pradax in Canada) for the prevention of venous thromboembolic events (VTE), from Health Canada. On June 10, 2008, Health Canada issued a Notice of Compliance to Boehringer Ingelheim Canada Ltd. for the drug product, Pradax. Pradax contains the medicinal ingredient dabigatran etexilate used in its salt form, dabigatran etexilate […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos